- NEWS AND VIEWS
Promising reversible protein inhibitors kept on target
Access options
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
Nature 603, 583-584 (2022)
doi: https://doi.org/10.1038/d41586-022-00692-5
References
Singh, J., Petter, R. C., Baillie, T. A. & Whitty, A. Nature Rev. Drug. Discov. 10, 307–317 (2011).
De Vita, E. Future Med. Chem. 13, 193–210 (2021).
Reja, R. M., Wang, W., Lyu, Y., Haeffner, F. & Gao, J. J. Am. Chem. Soc. 144, 1152–1157 (2022).
Serafimova, I. M. et al. Nature Chem. Biol. 8, 471–476 (2012).
Yan, T. et al. ChemBioChem 22, 1841–1851 (2021).
Hacker, S. M. et al. Nature Chem. 9, 1181–1190 (2017).
Abbasov, M. E. et al. Nature Chem. 13, 1081–1092 (2021).
Vichinsky, E. et al. N. Engl. J. Med. 381, 509–519 (2019).
Cal, P. M. S. D. et al. J. Am. Chem. Soc. 134, 10299–10305 (2012).
Akcay, G. et al. Nature Chem. Biol. 12, 931–936 (2016).
Competing Interests
The author declares no competing interests.